BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7729425)

  • 1. Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A.
    Schouten GJ; van der Eb AJ; Zantema A
    EMBO J; 1995 Apr; 14(7):1498-507. PubMed ID: 7729425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced binding activity of transcription factor NF-kappa B accounts for MHC class I repression in adenovirus type 12 E 1-transformed cells.
    Meijer I; Boot AJ; Mahabir G; Zantema A; van der Eb AJ
    Cell Immunol; 1992 Nov; 145(1):56-65. PubMed ID: 1423646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first exon of Ad12 E1A excluding the transactivation domain mediates differential binding of COUP-TF and NF-kappa B to the MHC class I enhancer in transformed cells.
    Kushner DB; Pereira DS; Liu X; Graham FL; Ricciardi RP
    Oncogene; 1996 Jan; 12(1):143-51. PubMed ID: 8552385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A.
    Proffitt JL; Sharma E; Blair GE
    Nucleic Acids Res; 1994 Nov; 22(22):4779-88. PubMed ID: 7984430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In adenovirus type 12 tumorigenic cells, major histocompatibility complex class I transcription shutoff is overcome by induction of NF-kappaB and relief of COUP-TFII repression.
    Hou S; Guan H; Ricciardi RP
    J Virol; 2002 Apr; 76(7):3212-20. PubMed ID: 11884545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of a nuclear NF-kappa B inhibitor in global down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells.
    Liu X; Ge R; Ricciardi RP
    Mol Cell Biol; 1996 Jan; 16(1):398-404. PubMed ID: 8524321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5- versus Ad12-transformed cells.
    Nielsch U; Zimmer SG; Babiss LE
    EMBO J; 1991 Dec; 10(13):4169-75. PubMed ID: 1756724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.
    Blanchet O; Bourge JF; Zinszner H; Israel A; Kourilsky P; Dausset J; Degos L; Paul P
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3488-92. PubMed ID: 1565643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin repression by COUP-TFII and HDAC dominates activation by NF-kappaB in regulating major histocompatibility complex class I transcription in adenovirus tumorigenic cells.
    Zhao B; Hou S; Ricciardi RP
    Virology; 2003 Feb; 306(1):68-76. PubMed ID: 12620799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-regulated expression of junB and MHC class I genes in adenovirus-transformed cells.
    Meijer I; van Dam H; Boot AJ; Bos JL; Zantema A; van der Eb AJ
    Oncogene; 1991 Jun; 6(6):911-6. PubMed ID: 1906158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A protein.
    Brockmann D; Schäfer D; Kirch HC; Esche H
    Oncogene; 1996 Apr; 12(8):1715-25. PubMed ID: 8622892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding.
    Ge R; Kralli A; Weinmann R; Ricciardi RP
    J Virol; 1992 Dec; 66(12):6969-78. PubMed ID: 1433502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element.
    Kralli A; Ge R; Graeven U; Ricciardi RP; Weinmann R
    J Virol; 1992 Dec; 66(12):6979-88. PubMed ID: 1433503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.
    Brown AM; Linhoff MW; Stein B; Wright KL; Baldwin AS; Basta PV; Ting JP
    Mol Cell Biol; 1994 May; 14(5):2926-35. PubMed ID: 8164652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced phosphorylation of p50 is responsible for diminished NF-kappaB binding to the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells.
    Kushner DB; Ricciardi RP
    Mol Cell Biol; 1999 Mar; 19(3):2169-79. PubMed ID: 10022903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-kappa B and KBF1 in murine macrophages.
    Brown MC; Taffet SM
    Infect Immun; 1995 May; 63(5):1960-8. PubMed ID: 7729908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.
    van 't Veer LJ; Beijersbergen RL; Bernards R
    EMBO J; 1993 Jan; 12(1):195-200. PubMed ID: 8428579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.
    Plaksin D; Baeuerle PA; Eisenbach L
    J Exp Med; 1993 Jun; 177(6):1651-62. PubMed ID: 8496683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.